DCM
SRDX

Dupont Capital Management’s Surmodics SRDX Stock Holding History

Dupont Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,343
Closed -$208K – 1402
2020
Q3 		$208K Sell
5,343
-358
-6% -$15.7K ﹤0.01% 1106
2020
Q2 		$247K Buy
+5,701
New +$216K 0.01% 1050

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dupont Capital Management's SRDX Position: Q4 2020 in Review

Dupont Capital Management sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 5,343 shares — an estimated $208K sold.

Dupont Capital Management first reported a position in SRDX in Q2 2020 and held it in 2 quarters. The position peaked at $247K in Q2 2020. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.

  • Dupont Capital Management reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
  • Dupont Capital Management sold 5,343 Surmodics shares in Q4 2020, an estimated $208K.
  • Dupont Capital Management first reported a position in Surmodics in Q2 2020 and held it in 2 quarters.
  • Dupont Capital Management's Surmodics position peaked at $247K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.

Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.